CNC CENTENE CORP
Hospital & Medical Service Plans · NYSE · SEC CIK 1071739 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $50.65B | $53.58B | $49.94B | $49.73B | $49.69B | $48.74B | $46.62B | $40.80B |
| Cost of revenue | $675.00M | $729.00M | $702.00M | $680.00M | $651.00M | $641.00M | $698.00M | $688.00M |
| Gross profit | $3.30B | $4.62B | $5.65B | $2.56B | $3.35B | $3.02B | $5.29B | $3.80B |
| SG&A expense | $3.23B | $3.10B | $3.40B | $3.37B | $3.15B | $3.04B | $3.35B | $3.23B |
| Operating income | -$307.00M | $1.20B | $1.86B | -$1.75B | -$6.95B | -$458.00M | $1.53B | $175.00M |
| Interest expense | $149.00M | $153.00M | $164.00M | $168.00M | $170.00M | $170.00M | $170.00M | $172.00M |
| Pretax income | -$122.00M | $1.49B | $2.10B | -$1.54B | -$6.67B | -$257.00M | $1.75B | $347.00M |
| Income tax | -$57.00M | $399.00M | $560.00M | -$443.00M | -$42.00M | $2.00M | $432.00M | $67.00M |
| Net income | -$71.00M | $1.09B | $1.54B | -$1.10B | -$6.63B | -$253.00M | $1.31B | $283.00M |
| EBITDA | -$169.00M | $1.34B | $2.16B | -$1.42B | -$6.81B | -$317.00M | $1.85B | $489.00M |
| EPS (basic) | -0.14 | 2.21 | 3.13 | — | -13.50 | -0.51 | 2.64 | — |
| EPS (diluted) | -0.14 | 2.19 | 3.11 | — | -13.50 | -0.51 | 2.63 | — |
| Weighted avg. shares (diluted) | 494.14M | 497.64M | 495.59M | — | 491.14M | 493.55M | 498.18M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $20.70B | $24.15B | $21.26B | $17.89B | $17.06B | $14.51B | $14.81B | $14.16B |
| Short-term investments | $2.89B | $2.91B | $2.48B | $2.43B | $2.18B | $2.77B | $2.47B | $2.62B |
| Current assets | $45.46B | $46.69B | $44.99B | $40.37B | $44.06B | $40.39B | $41.29B | $38.00B |
| PP&E, net | $2.11B | $2.13B | $2.09B | $2.04B | $2.16B | $2.12B | $2.04B | $2.07B |
| Goodwill | $10.84B | $10.84B | $10.84B | $10.84B | $10.84B | $17.56B | $17.56B | $17.56B |
| Intangibles | $4.04B | $4.20B | $4.36B | $4.53B | $4.84B | $5.01B | $5.24B | $5.41B |
| Total assets | $79.28B | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B |
| Current liabilities | $39.07B | $40.76B | $40.05B | $36.72B | $40.63B | $36.79B | $37.14B | $34.26B |
| Short-term debt | $88.00M | $75.00M | $63.00M | $50.00M | $38.00M | $25.00M | $12.00M | $110.00M |
| Long-term debt | $15.45B | $16.03B | $16.31B | $17.35B | $17.55B | $17.55B | $18.31B | $18.42B |
| Total debt | $15.54B | $16.11B | $16.37B | $17.40B | $17.58B | $17.58B | $18.32B | $18.53B |
| Total liabilities | $56.97B | $60.35B | $59.65B | $56.69B | $61.03B | $58.89B | $59.02B | $55.94B |
| Shareholders' equity | $22.21B | $22.56B | $21.43B | $19.95B | $20.95B | $27.41B | $27.92B | $26.41B |
| Net debt | -$5.16B | -$8.05B | -$4.89B | -$487.00M | $525.00M | $3.06B | $3.50B | $4.38B |
| Shares outstanding | 494.97M | 493.99M | 493.77M | 491.76M | 491.41M | 491.13M | 497.52M | 495.91M |
| Cash flow statement | ||||||||
| Operating cash flow | -$3.67B | $3.59B | $4.37B | $437.00M | $1.36B | $1.78B | $1.51B | -$587.00M |
| Capital expenditure | $194.00M | $174.00M | $200.00M | $213.00M | $211.00M | $208.00M | $135.00M | $154.00M |
| Free cash flow | -$3.86B | $3.42B | $4.17B | $224.00M | $1.15B | $1.58B | $1.38B | -$741.00M |
| Investing cash flow | $916.00M | -$353.00M | $89.00M | $660.00M | $1.24B | -$899.00M | -$529.00M | $102.00M |
| Financing cash flow | -$584.00M | -$259.00M | -$1.06B | -$187.00M | -$10.00M | -$1.17B | -$250.00M | -$13.00M |
| Depreciation & amortization | $138.00M | $139.00M | $300.00M | $329.00M | $147.00M | $141.00M | $314.00M | $314.00M |
| Stock-based compensation | $52.00M | $59.00M | $67.00M | $58.00M | $52.00M | $35.00M | $59.00M | $31.00M |
| Share buybacks | $24.00M | $4.00M | $29.00M | $2.00M | $0 | $432.00M | $41.00M | $943.00M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.